Applied Spectral Imaging

Applied BioCode Announces the Launch of the Fungal Panel Assay for Research Use

Retrieved on: 
Monday, June 12, 2023
Research, Technology, Infectious Diseases, Other Technology, Other Health, Biotechnology, Pharmaceutical, Health, Science, Other Science, EUA, UDM, Hair, Infection, Bachelor, BMB, Allergy, Workflow, RPP, Culture, SARS-CoV-2, Software, Pneumocystis jirovecii, COVID-19, Eye, Aspergillus, Histoplasma capsulatum, CE marking, PCR, Nomenclature codes, Immunochemistry, Emergency Use Authorization, Federal Food, Drug, and Cosmetic Act, Panel, Coccidioides, RSV, RUO, Patient, Laboratory, Autoimmune disease, Molecular Probes, IVD, Growth, GPP, Immunodeficiency, Diagnosis, FDA, Mucor, Virus, Vaccine, Rhizopus, Applied Spectral Imaging, Rhizomucor, Fusarium, Cunninghamella, Cryptococcus

The Fungal Panel Assay was developed to detect the most common agents of invasive fungal infections (IFIs) particularly in lower respiratory samples.

Key Points: 
  • The Fungal Panel Assay was developed to detect the most common agents of invasive fungal infections (IFIs) particularly in lower respiratory samples.
  • Applied BioCode’s Fungal Panel is intended for research use only and may be used in infectious disease research or pharmaceutical development.
  • “Applied BioCode is thrilled to announce our first release of an RUO panel under our new product strategy.
  • Applied BioCode, Inc. has also been granted an Emergency Use Authorization (EUA) from the U.S. FDA for its BioCode® SARS-CoV-2 Flu Plus Assay ⱡ, BioCode® SARS-CoV-2 Assay*, and an additional EUA for Pooled COVID-19 Testing*.

Global Hyperspectral Imaging Systems Market Report 2022 to 2027: Industry Trends, Share, Size, Growth, Opportunities and Forecasts

Retrieved on: 
Friday, January 27, 2023
Corning Inc., Mining, Applied Spectral Imaging, Telop, Diagnosis, Spectral imaging, Cell, NEO, Light, Food, COVID-19, Absorption, Porter's five forces analysis, SWOT, Physiology, R, Consultant, Agriculture, Unmanned aerial vehicle, System, Research, Tissue, Semiconductor, Video game, Medical imaging, Potash, Growth, Specim

DUBLIN, Jan. 27, 2023 /PRNewswire/ -- The "Hyperspectral Imaging Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Jan. 27, 2023 /PRNewswire/ -- The "Hyperspectral Imaging Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
  • The global hyperspectral imaging systems market size reached US$ 13.7 Billion in 2021.
  • The publisher's latest report provides a deep insight into the global hyperspectral imaging systems market covering all its essential aspects.
  • What is the structure of the global hyperspectral imaging systems market and who are the key players?

Applied BioCode Announces Exclusive Partner Distribution Agreement with Hardy Diagnostics, Further Broadens Reach of BioCode® MDx-3000 System into Hospitals and Reference Laboratories in the United States

Retrieved on: 
Monday, March 14, 2022
Manufacturing, Women, Men, Consumer, Other Travel, Other Communications, Travel, Marketing, Small Business, Communications, Other Automotive, Telecommunications, Software, Internet, Science, Finance, Data Management, Consumer Electronics, Banking, Automotive, Technology, Accounting, Professional Services, Vacation, Mining, Minerals, Semiconductor, Agriculture, Natural Resources, Utilities, Research, Other Manufacturing, Nanotechnology, Audio, Video, Energy, Engineering, Chemicals, Plastics, Federal Food, Drug, and Cosmetic Act, Virus, Laboratory, Hardy, Company, Analyte-specific reagent, Hardy Diagnostics, Allergy, FDA, RSV, EUA, RPP, LDT, Infection, CE marking, GPP, Respiratory tract, ASRS, Hospital, Nomenclature codes, Immunochemistry, IVD, Applied Spectral Imaging, Emergency Use Authorization, Hair, BMB, Autoimmune disease, COVID-19, Microbiology, Molecular Probes, Severe acute respiratory syndrome coronavirus 2, Medical degree, Diagnosis, Medical device, Vaccine

Under the terms of the exclusive agreement, Hardy Diagnostics will begin offering the MDx-3000 System to clinical laboratory customers in the United States.

Key Points: 
  • Under the terms of the exclusive agreement, Hardy Diagnostics will begin offering the MDx-3000 System to clinical laboratory customers in the United States.
  • Applied BioCode is thrilled to partner with Hardy Diagnostics, and we look forward to working closely with the Hardy team to expand our reach to hospitals and reference laboratories in the US, said Winston Ho, President of Applied BioCode.
  • Jay Hardy, Chief Executive Officer of Hardy Diagnostics, said, "We are very excited to add the Applied BioCode MDx-3000 molecular platform to our lineup of instruments to streamline the processes for microbiologists."
  • Hardy adds, "Our Company prides itself on offering our laboratory partners innovative solutions to detect and diagnose disease.

Spectral launches Spectral Logs to Ensure Sensitive Data Isn't Accidentally Exposed

Retrieved on: 
Wednesday, July 14, 2021
Data security, Computer network security, Computer security, Cryptography, Cybercrime, Data protection, Malware, Applied Spectral Imaging, Medical technology, Technology

TEL AVIV, Israel, July 14, 2021 /PRNewswire/ -- Spectral , the developer-first cybersecurity company, today announced the release of Spectral Logs, a detection technology that ensures that sensitive user data and system information are not accidentally leaking into their log files.

Key Points: 
  • TEL AVIV, Israel, July 14, 2021 /PRNewswire/ -- Spectral , the developer-first cybersecurity company, today announced the release of Spectral Logs, a detection technology that ensures that sensitive user data and system information are not accidentally leaking into their log files.
  • Spectral code, data, and logs are not tightly coupled so users can secure one without the other to achieve full security through their CI/CD pipeline.
  • Spectral recognized the need for a new scanning solution specifically for logs when it witnessed how easily sensitive data inadvertently sprawled into the logs.
  • However, that may risk exposing sensitive information, such as secrets, passwords, medical data, and personal information on these logs," said Dotan Nahum, CEO and founder of Spectral.

Global Mobile Imaging Services Markets 2021-2028 - Integration of Machine Learning and Advanced Computation With Medical Imaging - ResearchAndMarkets.com

Retrieved on: 
Monday, June 28, 2021
Technology, Mobile, Wireless, Health, Medical devices, Medical imaging, Applied Spectral Imaging, Biological engineering, Biomedical engineering, Imaging, Medical technology, Medicine, Life sciences

The publisher implies that the global mobile imaging services market is assessed to display growth at a CAGR of 4.62% over the assessed period 2021-2028.

Key Points: 
  • The publisher implies that the global mobile imaging services market is assessed to display growth at a CAGR of 4.62% over the assessed period 2021-2028.
  • Factors such as proactive government initiatives, growing occurrence of chronic disorders, and increasing geriatric population are key factors that add to the growth of the mobile imaging services market.
  • Several governments are taking initiatives to support hospitals and research organizations in developing advanced imaging services.
  • The Asia-Pacific region is estimated to become the fastest evolving region in the mobile imaging services market.

Immunohistochemistry Market Size Poised To Rise At 7.8% CAGR By 2027, Due To Rising Occurrence of Persistent Sicknesses & Introduction of Technically Sophisticated IHC Systems | Million Insights

Retrieved on: 
Tuesday, June 22, 2021
Branches of biology, Biology, Life sciences, Protein methods, Applied Spectral Imaging, Biological engineering, Biomedical engineering, Medical imaging, IHC, Immunohistochemistry, Agilent Technologies

What are Key Factors Driving the Immunohistochemistry Market?

Key Points: 
  • What are Key Factors Driving the Immunohistochemistry Market?
  • Growing approvals by the regulatory organizations, increasing occurrence of the persistent sicknesses, along with the introduction of technically sophisticated Immunohistochemistry (IHC) systems are the factors, estimated to boost the enlargement of the market, for the period of the forecast.
  • As a result, an increase in the occurrence of these persistent diseases has caused an augmentation in the requirement for immunohistochemistry procedures.
  • Browse 120 page research report with TOC on "Global Immunohistochemistry Market" at: https://www.millioninsights.com/industry-reports/global-immunohistochemi...
    Million Insights segmented the global immunohistochemistry market based on End Use, Application, Product, and Region:
    Immunohistochemistry (IHC) Product Outlook (Revenue, USD Million, 2016 - 2027)

Proscia Lauded by Frost & Sullivan for Advancing the Standard of Cancer Research and Diagnosis with Its Concentriq® Platform

Retrieved on: 
Wednesday, June 16, 2021
Application software, Launchpad, Applied Spectral Imaging, Applications of artificial intelligence, Life sciences, Medical technology

Proscia's Concentriq platform accelerates the modernization efforts of even the largest networked laboratories to help them easily hit their quality, efficiency, and productivity targets.

Key Points: 
  • Proscia's Concentriq platform accelerates the modernization efforts of even the largest networked laboratories to help them easily hit their quality, efficiency, and productivity targets.
  • This computationally enabled platform serves as a launchpad for AI applications developed by both Proscia and third parties.
  • "Proscia's flagship Concentriq platform is an image management system that uniquely sits at the intersection of digital and computational pathology.
  • The Concentriq platform delivers significant value by being a singular solution for connecting distributed teams, data, and applications across the global enterprise.

Proscia Lauded by Frost & Sullivan for Advancing the Standard of Cancer Research and Diagnosis with Its Concentriq® Platform

Retrieved on: 
Wednesday, June 16, 2021
Application software, Launchpad, Applied Spectral Imaging, Applications of artificial intelligence, Life sciences, Medical technology

Proscia's Concentriq platform accelerates the modernization efforts of even the largest networked laboratories to help them easily hit their quality, efficiency, and productivity targets.

Key Points: 
  • Proscia's Concentriq platform accelerates the modernization efforts of even the largest networked laboratories to help them easily hit their quality, efficiency, and productivity targets.
  • This computationally enabled platform serves as a launchpad for AI applications developed by both Proscia and third parties.
  • "Proscia's flagship Concentriq platform is an image management system that uniquely sits at the intersection of digital and computational pathology.
  • The Concentriq platform delivers significant value by being a singular solution for connecting distributed teams, data, and applications across the global enterprise.

Lightspeed Microscopy, Inc. raises $4M in Series A Financing Round with Plans to Revolutionize Pathology

Retrieved on: 
Tuesday, June 15, 2021
Application software, Biology, Life sciences, Biomedical engineering, E-commerce software, Lightspeed, Pathology, Applied Spectral Imaging

SEATTLE, June 15, 2021 /PRNewswire/ -- Lightspeed Microscopy, Inc., an end-to-end 3D pathology platform, announced today it has raised $4 million in a Series A financing round.

Key Points: 
  • SEATTLE, June 15, 2021 /PRNewswire/ -- Lightspeed Microscopy, Inc., an end-to-end 3D pathology platform, announced today it has raised $4 million in a Series A financing round.
  • The round was led by Dynamk Capital and is expected to close with participation from additional investors by mid-July.
  • The platform is a complete solution that includes tissue labelling, tissue clearing, high-throughput imaging, cloud-based processing, and 3D digital analysis.
  • "By integrating multiple distinct disciplines, Lightspeed is positioned to both accelerate pathology in existing workflows and unlock entirely new insights by greatly increasing access and ease of 3D pathology.

ASI Government Awarded Treasury Department Small Business Prime Contractor of the Year for 2020

Retrieved on: 
Monday, May 10, 2021
Tax, Taxation in the United States, Federal Procurement Data System, General Services Administration, Government procurement in the United States, Internal Revenue Service, Government, ASI Government, Applied Spectral Imaging, Government procurement

b'ARLINGTON, Va., May 10, 2021 /PRNewswire/ --ASI Government, LLC (ASI) announced today that the company was selected as the Department of Treasury "Small Business Prime Contractor of the Year" for 2020 and was presented the award at an Office of Small and Disadvantaged Business ceremony.

Key Points: 
  • b'ARLINGTON, Va., May 10, 2021 /PRNewswire/ --ASI Government, LLC (ASI) announced today that the company was selected as the Department of Treasury "Small Business Prime Contractor of the Year" for 2020 and was presented the award at an Office of Small and Disadvantaged Business ceremony.
  • The solution retrieves original contracts of interest to verify actual contract data aligned with official public procurement data (FPDS-NG) to ensure compliance with DATA ACT requirements.
  • IRS tested ASI\'s solution through an incremental phased approach and ASI\'s solution remains in operation today.
  • About IRS, A Closer Look )\nASI\'s CEO, Tim Cooke, said, "The ASI Team is humbled and inspired by our selection as Small Business Prime Contractor of the Year for our work supporting IRS and Treasury.